ERX - A thread for everyone

Hey Thanks Mike111 and TFP - analysis appreciated.

Much better than some pictures of cats or whatever!

It does look like an extended (desperate?) attempt by the company to get the market interested in the potential value of the company, which they clearly believe is under valued. One of the problems we all have is knowing where OSI are wrt to EiRx. We know they signed a licensing deal. We know Eirx repeatedly state that subject to the license milestone payments will be due. We just don't know where we are on the OSI stated pipeline (PI, pre-clinical or just synthesised!). We can guess but that is all. It's a serious problem wrt to the OSI relation - and I'm not sure why it is obscure or if it is being obscured.

If they were at PI surely they would have stated it! vis-a-vis MGI loads of detail there. As you guys say depends the planned/expected news flow...


It still remains HIGH risk.